Hamrick, SE, Hansmann, G. Patent ductus arteriosus of the preterm infant. Pediatrics
2010; 125: 1020–1030.
Sehgal, A, McNamara, PJ. The ductus arteriosus: a refined approach. Semin Perinatol
2012; 36: 105–113.
Clyman, RI, Couto, J, Murphy, GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?
2012; 36: 123–129.
Benitz, WE. Patent ductus arteriosus: to treat or not to treat?
Arch Dis Child Fetal Neonatal Ed
2012; 97: 80–82.
Chawla, D. Patent ductus arteriosus: looking for the right approach of management. Indian Pediatr
2012; 49: 611–612.
El-Khuffash, A, Mertens, L. Early treatment of the patent ductus arteriosus: do we know what we are doing?
Pediatr Crit Care Med
2012; 13: 363–364.
Sehgal, A. Haemodynamically unstable preterm infant: an unresolved management conundrum. Eur J Pediatr
2011; 170: 1237–1245.
Lai, LS, McCrindle, BW. Variation in the diagnosis and management of patent ductus arteriosus in premature infants. Pediatr Child Health
1998; 3: 405–410.
Koch, J, Hensley, G, Roy, L, Brown, S, Ramaciotti, C, Rosenfeld, CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics
2006; 117: 1113–1121.
Benitz, WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?
2010; 30: 241–252.
Bose, CL, Laughon, MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed
2007; 92: 498–502.
Laughon, MM, Simmons, MA, Bose, CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?
Curr Opin Pediatr
2004; 16: 146–151.
Evans, NJ, Kluckow, M. Early significant ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child
1996; 75: 183–186.
Kluckow, M, Evans, NJ. High pulmonary blood flow, the duct and pulmonary haemorrhage. J Pediatr
2000; 137: 68–72.
Noori, S, McCoy, M, Friedlich, P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics
2009; 123: 138–144.
Pezzati, M, Vangi, V, Biagiotti, R, Bertini, G, Cianciulli, D, Rubaltelli, FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr
1999; 135: 733–738.
Sehgal, A, Ramsden, CA, McNamara, PJ. Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus. Neonatology
2012; 101: 120–127.
Patel, J, Roberts, I, Azzopardi, D, Hamilton, P, Edwards, AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res
2000; 47: 36–42.
Abdel-Hady, H, Nasef, N, Shabaan, AE, Nour, I. Patent ductus arteriosus in preterm infants: do we have the right answers?
Biomed Res Int
2013; 2013: 676192.
Evans, N. Echocardiographic assessment of the patent ductus arteriosus in the preterm infant. In Poets CF, Franz A, Koehne P (eds), Controversies Around Treatment of the Open Duct. Springer-Verlag, Berlin-Heidelberg, 2011, pp 37–54.
De Waal, KA, Zonnenberg, I. The definition of a hemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr
2012; 101: 247–251.
McNamara, PJ, Sehgal, A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed
2007; 92: 424–427.
Sinha, B. Controversies in management of patent ductus arterious in the preterm infant. J Pulmon Resp Med
2013; S13: 007.
Polin, RA. Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics
2012; 129: 1006–1015.
Cayabyab, R, McLean, CW, Seri, I. Definition of hypotension and assessment of hemodynamics in the preterm neonate. J Perinatol
2009; 29: 58–62.
Kluckow, M, Evans, N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr
1995; 127: 774–779.
Evans, N, Iyer, P. Assessment of ductus arteriosus shunt in preterm infants requiring ventilation: effect of interatrial shunt. J Pediatr
1994; 125: 778–785.
El Hajjar, M, Vaksmann, G, Rakza, T, Kongolo, G, Storme, L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed
2005; 90: 419–422.
Suzmura, H, Nitta, A, Tanaka, O. Diastolic flow velocity of left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int
2001; 43: 146–151.
Schmitz, L, Stiller, B, Koch, H, et al. Diastolic left ventricular function in preterm infants with a patent ductus arteriosus: a serial Doppler echocardiography study. Early Hum Dev
2004; 76: 91–100.
Kluckow, M, Evans, N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed
2000; 82: 182–187.
Sehgal, A, McNamara, PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?
Eur J Pediatr
2009; 168: 907–914.
Groves, AM, Kuschel, CA, Knight, DB, Skinner, JR. Echocardiographic assessment of blood flow volume in the superior vena cava and descending aorta in the newborn infant. Arch Dis Child Fetal Neonatal Ed
2008; 93: 24–28.
Freeman-Ladd, M, Cohen, JB, Carver, JD, et al. The hemodynamic effects of neonatal patent ductus arteriosus shunting on superior mesenteric artery blood flow. J Perinatol
2005; 25: 459–462.
Moons, KG, de Groot, JA, Linnet, K, Reitsma, JB, Bossuyt, PM. Quantifying the added value of a diagnostic test or marker. Clin Chem
2012; 58: 1408–1417.
Obuchowski, NA, Lieber, ML, Wians, FH, Jr.. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem
2004; 50: 1118–1125.
Johnson, GL, Breart, GL, Gewitz, MH, et al. Echocardiographic characteristics of premature infants with patient ductus arteriosus. Pediatrics
1983; 72: 864–871.